Dr. Pietro Spitali received fellowships from Telethon Foundation, Legato Ferrari Foundation, Duchenne Parent Project and ICE (Industria Chimica Emiliana) to start his graduate project at the Molecular Genetics Laboratory of the University of Ferrara, headed by Prof. A. Ferlini.
His main areas of interest were Duchenne muscle dystrophy, splicing regulation using antisense oligoribonucleotides and noncoding RNAs (ncRNAs) involved in gene regulation. He obtained his PhD in Molecular Genetics in 2010 at the University of Ferrara under supervision of Prof. A. Ferlini. Within his PhD project, he spent one year at the Human Genetics Department of the Leiden University Medical Center (LUMC, the Netherlands), in the DMD Genetic Therapy Group headed by Dr. Annemieke Aartsma-Rus.
Since September 2010, Pietro is working as a postdoctoral researcher in the group of Dr. Annemieke Aartsma-Rus. He is leading part of the biomarker work within the group, in particular the validation of candidate serum biomarkers and the involvement of genomic factors as disease modifiers. He is also investigating the transcriptional regulation of the DMD gene locus. His main interests are: non-invasive biomarkers, splicing regulation via antisense oligonucleotides, ncRNAs and accurate quantification of transcripts.